1997, Number 3
<< Back Next >>
Vet Mex 1997; 28 (3)
Lamb immunization against pneumonic pasteurellosis using different antigens of Pasteurella haemolytica A1
Aguilar RF, Jaramillo ML, Morales AJF, Trigo TFJ, Suárez GF
Language: English/Spanish
References: 45
Page: 221-229
PDF size: 774.18 Kb.
ABSTRACT
An evaluation in two stages to measure the protection of pneumonic pasteurellosis provided by different immunogens of
Pasteurella haemolytica A1 was conducted. It was first conducted under experimental conditions and afterwards on field trials. In the first stage, 42 lambs were randomly distributed in six groups. On day 0 of the experiment, Group A received subcutaneously, as an immunogen, a live culture in the logarithmic phase of
P. haemolytica with a 1 x 10
9 CFU/ml; Group B was the control group; Group C received a commercial bacterin; Group D was treated with a leukotoxin culture supernatant; Group E was inoculated with a soluble capsule extract (SCE) with leukotoxin and Group F was treated with SCE with leukotoxin plus the adjuvant. All animals were exposed on day 35 to the Parainfluenza virus type 3 (PI
3) intratracheally and intranasally and seven days later challenged with a field strain of
P. haemolytica transthoracically. The surviving sheep were euthanized on day 49 of the experiment to assess pulmonary lesions and to perform the bacteriological study of some organs. Rectal temperature was measured daily, and serum samples were taken on days 0,7, 14, 21, 28, 35, 41 and 49 of the experiment to determine the anticapsule and antileukotoxin antibody levels using indirect haemmoagglutination and the simple visual assay. The field evaluation was carried out on 12 farms in Coajomulco, Morelos, Mexico, were 320 lambs were divided into 4 groups of 80 animals each. Using the same method as mentioned above the dosageand the administration techniques were as follows: Group 1 received leukotoxin; Group 2 was treated with a comercial bacterin; Group 3 was used as the control and group 4 received a live bacteria. In this phase the challenge was natural and anticapsule and antileukotoxin antibody titrers were evaluated, determining morbility and mortality too. In the experimental phase the measurements of the levels of the anticapsule- and antileukotoxin antibodies were statistically higher (P ‹ 0.05) in the groups treated with the live bacteria, leukotoxin and commercial bacterin as compared to the rest of the groups. Furthermore, lesions found were more severe in groups B, E and F. In the field trial, Group 1 presented 3 (3.75%) animals which developed clinical pneumonia, while Group 2 presented 5 (6.25%) and Group 4 presented 4 (5%) ones. Control Group 3 included 23 lambs (28.75%) with clinical pneumonia. Group 1 presented fewer deaths and higher anticapsule and antileukotoxin antibody titrers than control Group 3 (P ‹ 0.05). Results obtained in both phases suggest that the leukotoxin and the live bacteria are an important option in the prevention of pneumonia, and that research must continue regarding the different immunogens used, as well as searching for new options.
REFERENCES
Babiuk, LA., Morsey, M., Campos, M. and Harland, R.: Viral-bacterial synergy. International Conference of Haemophilus, Actinobacillus and Pasteurella. Edinburgh, Scotland, UK. 1994.21. Edinburgh, Scotland, U.K (1994).
Balayut, C.S., Simonson, R.R., Demrick, N.J. and Maheswaran, S.K: Interaction of Pasteurelia haemolytica with bovine neutre phils: Identification and partial characterization of a cytotoxin. Am. J. vet. Res., 42 1920-1926 (1981).
Biberstein, E.L.: Biotyping and serotyping of Pasteurella haemolytica In: Methods in Microbiology. Edited by: Bergep, T., Norris, J.R., 253269. AcademicPress, New York, 1978.
Bowersock, T.L., Shalaby, W.S., Ley, M., Samuels, M.L., Lallone, R, White, RM., Borie, D.L., Lehmeyer, J. and Park, El: Evaluation of an orally administered vaccine using hydrogels containing bacterial exotoxins of Pasteurella haemolytica in cattle. Am. J. vet. Res., 55: 502-509 (1994).
Brogden, AK, DeBey, B., Audibert, F., Lehmkuhl, H. and Chedid, L.: Protection of ruminants by Pasteurella haemolytica A1 capsular polysaccharide vaccines containing muramyl dipeptide analogs. Vaccine, 13: 1667-1684 (1995).
Brogden, A.K, DeBey, B. and Cutlip, R.: Lesions induced in vivo by cell-associated products of Pasteurella haemolytica and their role in the pathogenesis of bovine respiratory disease. Memorias del Seminario Pasteurelosis Neumónica del Ganado Bovino. Monterrey, N.L., México. 1995. 23-29. Universidad Autónoma de Nuevo León. Monterrey, N.L., México (1995).
Burrows, L.L., Olah-Winfield, E. and Lo, R.Y.C.: Molecular analysis of leukotoxin determinants from Pasteurella haemolytica serotypes 1 to 16. Infect. Immun., 61: 5001-5007 (1993).
Collins, M.T., Suárez-Güemes, F., Pierson, R.E. and Whiteman, C.E.: Effect of hydrocortisone on circulating lymphocyte numbers and their mitogen-induced blastogenesis in lambs. Am. J. vet. Res., 46: 1-5 (1985).
Confer, A.W., Panciera, R.J., Gentry, M.J., Fulton, R.W. and Rummage, J.A.: Effect of vaccination with live or killed Pasteurella haemolytica on resistance to experimental bovine pneumonic pasteurellosis. Am. J. vet. Res., 46: 342-347 (1985).
Confer, A.W., Panciera, R.J., Gentry, M.J. and Fulton, RW.: Immunologic response and resistance to experimentally induced pneumonic pasteurellosis in cattle vaccinated with various dosages of lyophilized Pasteurella haemolytica. Am. J. vet. Res., 47: 1853-1857 (1986).
Chae, C.H., Gentry, M.J., Confer, A.W. and Anderson, G.A.: Resistance to host immune defense mechanisms affored by capsular material of Pasteurella haemolytica serotype 1. Vet. Microbiol., 25: 241-251 (1990).
Derek, A.M., Simons, K.R., Confer, A.W., Panciera, R.J. and Clinkenbeard, K.D.: Pasteurella haemolytica antigens associated with resistance to pneumonic pasteurellosis. Infect. Immun., 57: 711-716 (1989).
Donachie, W.: Vaccine development against Pasteurella haemolytica infections in sheep. International Conference of Haemophilus, Actinobacillus and pasteurella, Edinburgh, Scotland, U.K. 1994. 18-19. Edinburgh, Scotland, U.K. (1994).
Durkham, J.A., Confer, A.W., Mosier D.A. and Lessiey, B.A.: Comparison of the antigens associated with saline solution, pottasium tiocyanate and sodium salicilate extract of Pasteurella haemolytica serotype 1. Am. J. vet. Res., 47: 1946-1951 (1986).
Filion, L.A., McGuire, R.L. and Babiuk, L.A.: Non specific sup pressive effect of bovine herpes virus type 1 on bovine leucocyte function. Infect. Immun., 42 106-112 (1983).
Filion, L.A., Wilson, P.J. and Bielefeldt-Ohmann, H.: The possible role of stress on the induction of pneumonic pasteurellosis. Can. J. comp. Med., 48: 268-274 (1984).
Gentry, M.J., Confer, A.W. and Kops, J.A.: Simple visual assay for determination of Pasteurella haemolytica cytotoxic neutralization antibody titrers in cattle sera. J. Clin. Microbiol., 22: 763-772 (1985).
Hernández, Z.J., Tórtora, P.J., Martínez, H.A. y Pijoan, A.P.: Determinación de las principales causas de mortalidad en Corderos en explotaciones del Estado de México. Memorias de la Reunión Anual de Investigación Pecuaria. México, D.F., 1985. 110. Instituto Nacional de Investigaciones Forestales y Agropecuarias. 1985. México, D.F. (1985).
Jean, Y.H. and Bak, U.B.: Pathological studies on the calf pneumonia experimentally induced by endotoxin and leukotoxin of Pasteurella haemolytica A1. J. agric. Sci. Vet., 35: 643-658 (1993).
Jensen, R.R, Pierson, P.E., Weitel, J.C., Tucker, J.O. and Swift, B.L.: Middle ear infection in feedlot lambs. J. Am. vet. med. Ass., 181: 805-807 (1982).
Jones, G.E., Donachie, W., Sutherland, A.D., Knox, D.P. and Gilmour, J.S.: Protection of lambs against experimental pneumonic pasteurellosis by transfer of immune serum. Vet. Microbiol, 19: 175-181 (1989).
Kiorpes, A.L., Collins, M.T., Goerke, T.P., Traul, D.L., Confer, A.W., Gentry, M.J. and Baumann, L.E.: Immune response of neonatal lambs to a modified live Pasteurella haemolytica vaccine. Small. Rumin. Res., 4: 73-84 (1991).
Lehmkuhl, H.D., Contreras, J.A., Cutlip, R.C. and Brodgen, A.K.: Clinical and microbiologic findings in lambs inoculated with Pasteurella haemolytica after infection with ovine adenovirus type 6. Am. J. vet. Res., 50: 671-675 (1989).
Malore, F.C., MacCullough, G.J., MacLoughlin, M.T., Rall, H.J., Ohagan, J. and Neill, S.D.: Infectious agents in respiratory disease of housed fattening lambs of Northern Ireland. Vet. Rec., 122: 203-207 (1988).
Markham, R.J. and Wilkie, B.N.: Interaction between Pasteurella haemolytica and bovine alveolar macrophages. Cytotoxic effect on macrophage and impaired phagocytosis. Am. J. vet. Res., 41: 10-22 (1980).
Moiser, D.A., Confer, A.W. and Panciera, R.J.: The evolution of vaccines of bovine pneumonic pasteurellosis. Res. vet. Sci., 47: 1-10 (1989).
Morales, A.J.F., Jaramillo, M.L., Oropeza, V.Z., Tórtora, P.J.L., Trigo, T.J.F. y Espino, R.G.: Evaluación experimental de un inmunógeno de Pasteurella haemolytica en corderos. Vet. Méx., 24: 97-105 (1993).
Morck, D.W., Olson, M.E., Acres, S.D., Daoust, P.Y. and Costerton, J.W.: Presence of bacterial glycocalix and fimbriae on Pasteurella haemolytica in feedlot cattle with pneumonic pasteurellosis. Can. J. vet. Res., 53: 167-171 (1989).
Moore, R.N., Walker, RD., Shaw, G.A., Hopkins, F.M. and Shull, E.P.: Antileukotoxin antibody produced in the bovine lung after aeroexposure to viable Pasteurella haemolytica. Am. J. vet. Res., 46: 1949-1952 (1985).
Panciera, R.J., Corstvet, R.E., Confer, A.W. and Gresham, C.N.: Bovine pasteurellosis: Effect of vaccination with live Pasteurella species. Am. J. vet. Res., 45: 2538-2542 (1984).
Pérez, G.E.: Curso de Epidemiología Básica. Mérida, Yucatán, México. 1994. 45. Agencia Internacional de Energía Atómica. Austria, Viena (1994).
Ramírez, RR. y Brodgen, A.K.: Patogénesis del daño pulmonar provocado por Pasteurella haemolytica. Rev. Latinoam. Microbiol., 37: 353-365 (1995).
SAS Institute Inc.: SAS User's Guide Basics. SAS Institute Inc, Cary, North Carolina, 1982.
Schimmel, D., Erler, W. and Feist, H.: Experimental immunization of calves with various Pasteurella antigens. Deutsche-Tierärzt. Wchschtrft., 99: 204-206 (1992).
Segura, J. y Honhold, N.: Manual de Muestreo para la Salud y Producción Animal. Facultad de Medicina Veterinaria y Zootecnia, Universidad Autónoma de Yucatán, Mérida, Yucatán, México, 1993.
Shewen, P.E. and Wilkie, B.N.: Pasteurella haemolytica cytotoxin: Production by recognized serotypes and neutralization by type specific rabbit antisera. Am. J. vet. Res., 44: 715-719 (1983).
Shewen, P.E. and Wilkie, B.N.: Vaccination of calves with leucotoxic culture supernatant from Pasteurella haemolytica. Can. vet. Res., 52: 30-36 (1988). ,
Srinand, S., Ames, T.R., Maheswaran, S.K. and King, V.L.: Efficacy of various vaccines against pneumonic pasteurellosis in cattle: A meta-analysis. prev. vet. Med., 25: 7-17 (1995).
Suarez-Guemes, F., Collins, M.T., Whiteman, W.E. and Pierson, R.E.: Serum cortisol levels in clinical normal feedlot lambs and clinicopathological features of septicemic pasteurellosis. Rev. Latinoam. Microbiol., 28: 253-257 (1986).
Sutherland, A.D., Donachie, W., Jones, G.E. and Quirie, M.: A crude cytotoxin vaccine protects sheep against experimental Pasteurella haemolytica serotype A-2 infection. Vet. Microbiol., 19: 175-181 (1989).
Thompson, R.G.: Special Veterinary Pathology. B.C. Decker, Philadelphia, 1994.
Thrusfield, M.: Epidemiología Veterinaria. Acribia, Zaragoza, España, 1990.
Trigo, J.F. y Romero, J.: La relevancia de las neumonías como causa de mortalidad en corderos. Vet. Méx., 17: 116-119 (1986).
Trigo, T.J.F.: El complejo respiratorio infeccioso de los bovinos. Memorias del Seminario Pasteurelosis Neumónica del Ganado Bovino. Monterrey, N.L., México. 1995. 18-22. Universidad Autónoma de Nuevo León. Monterrey, N.L., México (1995).
Younan, M. and Fodor, L.: Characterization of a new Pasteurella haemolytica serotype (A17). Res. vet. Sci., 58: 98 (1995).